FDA Drug recall D-1501-2014
Azor Tablets (amlodipine and olmesartan medoxomil) 10 mg*/40 mg, 30 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc
- FDA Drug
- Class II
- terminated
- Published 2014-08-06
On 2014-08-06 the FDA classified a Class II recall of Azor Tablets (amlodipine and olmesartan medoxomil) 10 mg*/40 mg, 30 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc by Daiichi Sankyo Pharma Development, citing temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1501-2014 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2014-07-12 |
| Published | 2014-08-06 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Daiichi Sankyo Pharma Development |
| Distribution | US |
Product
Azor Tablets (amlodipine and olmesartan medoxomil) 10 mg*/40 mg, 30 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc. Parsippany, NJ 07054 NDC 65597-113-30
Reason
Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping
Identifiers
| code_info | Lot #213655B Exp - 12/31/2017 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1501-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.